We are delighted to share that Panakeia has been included in the finalist list for the OBN Awards 2022 in the Best Emerging Medtech Company category. Congratulation to all the other nominees and good luck to everyone for the finals at the #OBNAwards, on Thursday 17th November at the Royal Lancaster London. Read more...
top of page
Search
PANProfiler Colon determines MSI/dMMR status in minutes from colon cancer tissue samples Entirely digital, AI-driven molecular profiling...
bottom of page
Comments